Cytomegalovirus Retinitis After the Initiation of Highly Active Antiretroviral Therapy: A 2 Year Prospective Study

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.83.6.652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Relapses of CMV Retinitis After 2 Years of Highly Active Antiretroviral Therapy

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients With AIDS in the Era of Highly Active Antiretroviral Therapy

Ophthalmology
Ophthalmology
2013English

Sclerosing Cholangitis by Cytomegalovirus in Highly Active Antiretroviral Therapy Era

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2013English

Ritonavir-Associated Toxicity Mimicking Retinitis Pigmentosa in an Hiv-Infected Patient on Highly Active Antiretroviral Therapy

Retinal Cases and Brief Reports
MedicineOphthalmology
2016English

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2007English

Incidence of Opportunistic Infections Among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2017English

Developing Useful Highly Active Antiretroviral Therapy Adherence Measures for India: The Prerana Study

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Evolution of Sensory Neuropathy After Initiation of Antiretroviral Therapy

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2017English

HIV-related Morbidity Rate, Thirteen Years After the Introduction of Highly Active Antiretroviral Therapy (1996-2009)

Retrovirology
VirologyInfectious Diseases
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy